Endocrine Oncology Journal Citation Rate 2026
2634-4793
eISSN 2634-4793
Bioscientifica
GB
Q3 Quartile Open Access Diamond OA
About Endocrine Oncology
Endocrine Oncology (EO) is a peer-reviewed academic journal covering Diseases of the endocrine glands. Clinical endocrinology and Neoplasms. Tumors. Oncology. Including cancer and carcinogens, published by Bioscientifica in GB and in circulation since 2023, catalogued under ISSN 2634-4793 (e-ISSN 2634-4793). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.75 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access and free to publish (no APC). It is indexed in DOAJ, among the databases we track. OpenAlex records 189 works and 507 citations, with an h-index of 11.
Authors typically receive a first decision in around 69 days.
Endocrine Oncology Citation Rate 2026 — In Context
Endocrine Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 0.75, placing it in the Q3 quartile within the Diseases of the endocrine glands. Clinical endocrinology research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Endocrine Oncology makes all articles freely available to readers. Average submission-to-decision turnaround is approximately 69 days.
Researchers looking to publish in Endocrine Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Endocrine Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for Endocrine Oncology
- Be prepared for a longer review cycle — decisions typically take around 69 days.
- As a Diamond Open Access journal, there are no publication fees — an excellent choice for researchers without grant funding.
- This journal covers Diseases of the endocrine glands. Clinical endocrinology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Endocrine Oncology Compares
Compared against 4 journals in the same research areas.
| ISSN (Print) | 2634-4793 |
|---|---|
| ISSN (Online) | 2634-4793 |
| Publisher | Bioscientifica |
| Country | United Kingdom |
| Established | 2023 |
| APC / Cost | Free (Diamond) |
| Review Speed | ~69 days to first decision |
| h-index | 11 |
| Total Works | 191 |
| Total Citations | 507 |
| 2-yr Mean Citedness | 0.78 (OpenAlex) |
| DOAJ | Listed |
In-depth profile & metrics
Endocrine Oncology is published by Bioscientifica, based in United Kingdom and in publication since 2023. It is a Diamond Open Access title, free for both readers and authors.
In our subject taxonomy, Endocrine Oncology is classified under Diseases of the endocrine glands. Clinical endocrinology and Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Endocrine Oncology is indexed in the DOAJ and OpenAlex. DOAJ listing confirms the journal's open-access policies have been independently vetted.
For prospective authors, Endocrine Oncology returns a first decision in about 69 days (longer for its field).
OpenAlex records 191 works that have together drawn 507 citations, giving the journal an h-index of 11; its most recent citation rate stands at 0.753; OpenAlex puts its two-year mean citedness at 0.78.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Endocrine Oncology
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.753 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2000–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 55 | 41 |
| 2024 | 23 | 35 |
| 2023 | 18 | 98 |
| 2022 | 25 | 222 |
| 2021 | 9 | 41 |
| 2003 | 20 | 16 |
| 2000 | 20 | 53 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Endocrine Oncology most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Journal Metrics
Compare Journals
Compare Endocrine Oncology against similar publications in its field:
Related Journals in Your Field
-
Journal of the Egyptian National Cancer Institute SpringerOpen IF 2.13
-
Cancer Research, Statistics, and Treatment Wolters Kluwer Medknow Publications IF 1.11
-
ESMO Real World Data and Digital Oncology Elsevier IF 0.63
-
Libri Oncologici University Hospital for Tumors IF 0.11
Explore More Journals
Metadata
Last updated: Jul 26, 2026
Updated by: system
Get weekly updates for Diseases of the endocrine glands. Clinical endocrinology journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.